INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 April 2014
|
Net Assets |
£180m |
|
Net Assets per share |
327p |
|
Share price |
271p |
|
Total value of unquoted investments |
£23m |
|
Total number of portfolio companies |
92 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Gilead |
7.6 |
|
Alexion |
7.3 |
|
Biogen |
6.9 |
|
Celgene |
5.9 |
|
Amgen |
4.0 |
|
Regeneron |
3.6 |
|
Mylan |
3.3 |
|
Aptiv |
3.1 |
|
Illumina |
3.1 |
|
Vertex |
3.0 |
|
|
----------- |
|
Total |
47.8 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
59 |
|
Turning Profitable 2015 |
10 |
|
Unprofitable |
31 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
United States & Canada |
91 |
|
Europe & UK |
9 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
87 |
|
Unquoted |
13 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
29 MAY 2014